Advanced Therapies Europe 2026

Advanced Therapies Europe is Phacilitate's European cell and gene therapy conference, gathering around 600 advanced-therapy leaders at the InterContinental Barcelona from 7-9 September 2026. The agenda spans clinical development, manufacturing and CMC, regulatory planning, market access and patient involvement, with a supply-chain roundtable on import/export, customs, chain-of-custody and compliance.

Cell and gene therapies are among the most demanding payloads in the cold chain — often cryogenic, frequently autologous and irreplaceable, and moved to tight clinical deadlines. The value here is proximity to the sponsors and manufacturers setting those handling requirements, and to the chain-of-custody and cross-border problems that shape how advanced therapies actually move. Note the cold-chain content is one session, not a stream.

Cell and gene therapy developers, CDMOs, manufacturing and supply-chain leads, regulatory and market-access specialists, investors, and service providers to the advanced-therapy sector. Senior and commercially weighted.